<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=213807269037206&amp;ev=PageView&amp;noscript=1">
IMARC Blog

Compliance In Focus

FILTER BY:

Newest Post

Posted by John Lehmann on Mon, Nov 06, 2017

Giving Your Studies a FAIR Shake™

Please take time to download and review IMARC Research’s white paper on the FAIR Shake™ training program.  The goal of this white paper is to introduce you to the concept of the FAIR Shake™ in an effort to foster a pattern of thinking that will allow you to navigate through the complexity of the regulatory framework in a very simple way that is based in regulatory fact as opposed to popular opinion.

Topics: FAIR Shake. Training Technique, IMARC Research

Posted by John Lehmann on Wed, Mar 04, 2015

21 CFR 312 vs. 812: What’s the Difference?

On Thursday, September 6th, BioEnterprise hosted an event at Corporate College in Cleveland, Ohio. The training event focused on the differences between investigational drug and medical device clinical trials.  Featured speakers for the event were Sandra Maddock, CEO and President of IMARC Research and Brandy Smith, Chief of Clinical Operations for IMARC Research.

Topics: BioEnterprise, 21 CFR 812, FAIR Shake. Training Technique, 21 CFR 312

requestconsult-bg.jpg
Clinical Research Training Requirements
Featured Resource

clinical research Training requirements

This whitepaper examines the similarities and differences between various US and international regulations and place them within the context of any number of roles found within the realm of clinical research.